CXCL8 and neoplasm: To verify the values of sequential therapy targeting IL8 after chemotherapy resistance, a xenograft mouse model was established using primary cells (BGC823-LPC) extracted from tumor tissues, which were subjected to first-line and second-line chemotherapy.